Stocks to watch today

has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Carbamazepine Extended-Release Tablets USP, 100 mg, 200 mg, and 400 mg. The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Tegretol-XR Extended-Release Tablets, 100 mg, 200 mg, and 400 mg, of Novartis Pharmaceuticals Corporation. Carbamazepine Extended-Release Tablets are indicated for use as an anticonvulsant drug and also for the treatment of the pain associated with true trigeminal neuralgia. Carbamazepine Extended-Release Tablets USP, 100 mg, 200 mg, and 400 mg, have an estimated market size of $71 million for twelve months ending March 2025 according to IQVIA. has reported result for first quarter ended June 30, 2025 (Q1FY26). The bank has reported 47.49% decline in its net profit at Rs 3,281.68 crore for the quarter ended June 30, 2025 as compared to Rs 6,249.82 crore for the same quarter in the previous year. However, total income of the bank increased by 7.92% at Rs 16,916.52 crore for Q1FY26 as compared to Rs 15,675.15 crore for the corresponding quarter previous year. On consolidated basis, the bank has reported 39.96% decline in net profit at Rs 4,472.18 crore for Q1FY26 as compared to Rs 7,448.16 crore for the same quarter in the previous year. However, total income of the bank increased by 6.49% at Rs 26,703.92 crore for Q1FY26 as compared to Rs 25,075.87 crore for the corresponding quarter previous year. L and Hindustan Shipyard (HSL) have signed a non-binding Memorandum of Understanding (MoU) to collaborate on the co-creation of advanced marine systems-encompassing innovation, indigenous design, manufacturing, and end-to end lifecycle support.